Fatima Mamnoon
YOU?
Author Swipe
View article: Concomitant bedaquiline and delamanid therapy in patients with drug-resistant extra-pulmonary tuberculosis in Mumbai, India
Concomitant bedaquiline and delamanid therapy in patients with drug-resistant extra-pulmonary tuberculosis in Mumbai, India Open
View article: Concomitant Bedaquiline and Delamanid Therapy in Patients with Drug-Resistant Extra-Pulmonary Tuberculosis in Mumbai, India
Concomitant Bedaquiline and Delamanid Therapy in Patients with Drug-Resistant Extra-Pulmonary Tuberculosis in Mumbai, India Open
View article: New TB drugs for the treatment of children and adolescents with rifampicin-resistant TB in Mumbai, India
New TB drugs for the treatment of children and adolescents with rifampicin-resistant TB in Mumbai, India Open
SETTING: Médecins Sans Frontières (MSF) clinic in Mumbai, India. OBJECTIVE: To determine the final treatment outcomes, culture conversion and adverse events (AEs) during treatment among children and adolescents (0–19 years) with rifampicin…
View article: One Step Forward: Successful End-of-Treatment Outcomes of Patients With Drug-Resistant Tuberculosis Who Received Concomitant Bedaquiline and Delamanid in Mumbai, India
One Step Forward: Successful End-of-Treatment Outcomes of Patients With Drug-Resistant Tuberculosis Who Received Concomitant Bedaquiline and Delamanid in Mumbai, India Open
Background The Médecins Sans Frontières Clinic in Mumbai, India, has been providing concomitant bedaquiline (BDQ) and delamanid (DLM) in treatment regimen for patients with drug-resistant tuberculosis (DR-TB) and limited therapeutic option…
View article: Correlation of body mass index, degree of airflow obstruction, dyspnea scale, and exercise index with pulmonary hypertension
Correlation of body mass index, degree of airflow obstruction, dyspnea scale, and exercise index with pulmonary hypertension Open